Gastrointestinal Cancer News

High muscle strength and cardiorespiratory fitness reduced mortality for people diagnosed with cancer, according to a systematic review and meta-analysis.

Use of a home-based electronic monitoring system for symptom reporting reduced ED visits among people receiving treatment for metastatic cancer, according to study findings.

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for direct-to-consumer products, according to a medical oncologist with expertise in cancer genetics.

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term mortality rates among people with advanced cancer, according to results of a cohort study.

Central obesity measures of waist circumference and waist-to-hip ratio appear to be more accurate and consistent indicators of colorectal cancer incidence compared with BMI, according to a study published in JAMA Network Open.

Zenocutuzumab exhibited efficacy among patients with NRG1 fusion-positive cancers, according to phase 2 data published in The New England Journal of Medicine.

Approximately one in three patients diagnosed with cancer in Ontario presented to an ED in the 90 days preceding their diagnosis, according to findings published in Canadian Medical Association Journal.

Oral anticoagulant or antiplatelet medication use had no substantial effect on the accuracy of multitarget stool DNA testing for colorectal cancer, according to a study published in Gastro Hep Advances.

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment locally at low-volume centers, according to results of a cohort study.